These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial. Blennow M; Granström M; Jäätmaa E; Olin P Pediatrics; 1988 Sep; 82(3):293-9. PubMed ID: 3043367 [TBL] [Abstract][Full Text] [Related]
63. Food and Drug Administration approval of an acellular pertussis vaccine for the initial four doses of the diphtheria, tetanus, and pertussis vaccination series. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1996 Aug; 45(31):676-7. PubMed ID: 8778580 [No Abstract] [Full Text] [Related]
64. Composition of acellular pertussis and combination vaccines: a general review. Jadhav SS; Gairola S Biologicals; 1999 Jun; 27(2):105-10. PubMed ID: 10600195 [TBL] [Abstract][Full Text] [Related]
65. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations. Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869 [TBL] [Abstract][Full Text] [Related]
66. [Efficacy of acellular pertussis vaccines]. Wirsing von König CH; Finger H Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115 [TBL] [Abstract][Full Text] [Related]
67. Immune responses to pertussis vaccines and disease. Edwards KM; Berbers GA J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958 [TBL] [Abstract][Full Text] [Related]
68. Overview of recent clinical trials of acellular pertussis vaccines. Miller E Biologicals; 1999 Jun; 27(2):79-86. PubMed ID: 10600188 [TBL] [Abstract][Full Text] [Related]
70. Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease? Granoff DM; Rappuoli R Dev Biol Stand; 1997; 89():379-89. PubMed ID: 9272376 [TBL] [Abstract][Full Text] [Related]
72. [Laboratory assessment problems of the efficacy of acellular pertussis vaccines]. Gzyl A Przegl Epidemiol; 2004; 58(2):361-7. PubMed ID: 15517817 [TBL] [Abstract][Full Text] [Related]
73. Development of acellular pertussis vaccines. Sato Y; Sato H Biologicals; 1999 Jun; 27(2):61-9. PubMed ID: 10600185 [TBL] [Abstract][Full Text] [Related]
74. Acellular pertussis vaccine scores high in trial. Marwick C JAMA; 1995 Jun; 273(24):1892-3. PubMed ID: 7783285 [No Abstract] [Full Text] [Related]